The solid-state form of an active pharmaceutical ingredient (API) in an oral dosage form plays an important role in determining the dissolution rate of the API. As the solid-state form can change during dissolution, there is a need to monitor the oral dosage form during dissolution testing. Coherent anti-Stokes Raman scattering (CARS) microscopy provides rapid, spectrally selective imaging to monitor the oral dosage form during dissolution. In this study, in situ CARS microscopy was combined with inline UV absorption spectroscopy to monitor the solid-state change in oral dosage forms containing theophylline anhydrate undergoing dissolution and to correlate the solid-state change with a change in dissolution rate. The results from in situ CARS microscopy showed that theophylline anhydrate converted to theophylline monohydrate during dissolution resulting in a reduction in the dissolution rate. The addition of methyl cellulose to the dissolution medium was found to delay the theophylline monohydrate growth and changed the morphology of the monohydrate. The net effect was an increased dissolution rate for theophylline anhydrate. Our results show that in situ CARS microscopy combined with inline UV absorption spectroscopy is capable of monitoring oral dosage forms undergoing dissolution and correlating changes in solid-state form with changes in dissolution rate.
Introduction
Active pharmaceutical ingredients (API) commonly exist in various crystalline forms, known as polymorphs, with different molecular arrangements and/or conformations. Multi-component crystals, where one or more additional compounds are incorporated into the crystal lattice, may also be formed and include salts, co-crystals, and solvates. A widely observed solvate is the hydrate, where water molecules have been incorporated into the API's crystal lattice. Single and multi-component API solids may also exist in a higher energy, disordered amorphous form.
The solid-state form of an API is an important parameter in the development of oral dosage formulations. It has an effect on the chemical and physical stability, processibility, solubility, dissolution rate, and potentially bioavailability of the API. In dynamic environments, solid-state changes in pharmaceutical materials are common: there have been numerous reports on solid-state forms undergoing changes during processing [1] [2] [3] and storage and dissolution [4] [5] [6] .
Solid-state changes that occur during dissolution when a metastable form (higher solubility) converts to a stable form (lower solubility) through precipitation from a supersaturated solution are called solvent-mediated phase transformations [7] . The kinetics of a solvent-mediated phase transformation are determined by the relative rates of dissolution and growth of the two phases [7, 8] . Solution-mediated transformations of APIs are well documented. Murphy et al. [5] studied the conversion of carbamazepine (CBZ) form III to the dihydrate form in samples undergoing dissolution testing. They found that the conversion time depended on grinding and storage conditions of the form III [5] . Savolainen et al. [9] studied the dissolution of amorphous indomethacin (IMC) and compared this to the dissolution of a and c forms of IMC. As expected, they found that the initial intrinsic dissolution rate for amorphous IMC was faster than for either crystalline form. However, the dissolution rate decreased as the sample surfaces began to crystallize to a-IMC during dissolution. Aaltonen et al. [10] have reported the conversion of theophylline (TP) anhydrate (TPa) to theophylline monohydrate (TPm) during dissolution testing.
Decreased dissolution rates due to solid-state transformations during dissolution testing have led to investigations into methods for preventing or reducing such transformations. A number of studies have found that some excipients are capable of inhibiting or delaying the hydrate formation. Katzhendler et al. [11] first reported hydroxypropylmethylcellulose (HPMC) inhibiting the transformation of CBZ to CBZ dihydrate on tablets in aqueous solutions. They suggest that hydroxyl groups from HPMC may attach to CBZ at the site of water binding, thereby inhibiting the growth of the dihydrate form. More recently, Wikstrom et al. [12] investigated the effect of pharmaceutical excipients on TPm formation during wet granulation. They found that the majority of excipients tested did not change the transformation kinetics of TP. However, polymeric binders such as methyl cellulose (MC) and HPMC could significantly inhibit the conversion of TPa to TPm during wet granulation. Wikstrom et al. [12] suggested that the inhibitory polymers adsorb to fast-growing surfaces of the hydrate crystal inhibiting crystal growth and causing morphological changes.
Dissolution testing is an important part of oral solid dosage form development since the dissolution behavior of a drug is a key determinant of therapeutic efficacy for many drugs. This is particularly important for poorly soluble drugs, as drugs must dissolve first before being absorbed [13] . Standard pharmacopoeial methods require the immersion of the drug (e.g., as a compact) in a flowing dissolution medium with samples of the dissolution medium being removed over a series of time intervals to be analyzed for drug concentration in solution using UV absorption spectroscopy or HPLC [14] . Analyzing solution concentration provides information about how much drug is dissolved. However, it does not give any direct information about physical changes on the surface of the dissolving dosage form, including solidstate changes, which can affect dissolution behavior. Direct analysis of the solid dosage form changes during dissolution testing can therefore provide improved understanding of dissolution behavior.
In situ analysis of the solid drug or dosage form during dissolution testing places a number of restrictions on the suitable analytical techniques. Firstly, the technique must be nondestructive to the sample. Secondly, the technique must be able to obtain data in the presence of dissolution medium with a sufficient temporal resolution (on the order of seconds) to observe rapid changes in the sample. Finally, the technique must not interfere with the dissolution process. Common solid-state techniques such as X-ray powder diffraction (XRPD), scanning electron microscopy (SEM), near infrared (NIR), and infrared (IR) spectroscopy all have limiting factors preventing their use in situ for dissolution. The radiation used in NIR and IR imaging is strongly absorbed by water limiting their use in aqueous environments [15, 16] . Scanning electron microscopy has been used to characterize solidstate changes on the surfaces of dosage forms after dissolution [10, 17] . X-ray powder diffraction has been used to depth profile phase changes on samples undergoing dissolution related solidstate changes [17] . However, both SEM and XRPD are unsuitable for in situ analysis of dissolution due to sample preparation requirements. Spontaneous Raman spectroscopy has been shown to be suitable for in situ analysis of solid-state transformations during dissolution [9, 10] . Spontaneous Raman spectroscopy has the advantage that it can generate full vibrational spectra in a relatively short period of time. Coupled with a flow through cell and UV flow through absorption spectroscopy, it has been used in situ to monitor various solid-state conversions and their effects on dissolution, including transformation from TPa to TPm, and the crystallization of amorphous IMC and CBZ. However, spontaneous Raman spectroscopy gives no spatial information, meaning that it is not capable of identifying where solid-state conversions are occurring during dissolution and techniques developed to map Raman intensity are slow (minutes to hours), precluding in situ analysis during dissolution testing.
Instead, we use coherent anti-Stokes Raman scattering (CARS) microscopy as a tool for in situ analysis during dissolution. A summary of CARS microscopy is provided in [18] . Briefly, CARS microscopy is capable of rapid spectrally-and spatially-resolved imaging allowing the visualization of different solid-state forms of drugs based on their Raman vibrational spectra. A narrowband CARS setup typically utilizes two synchronized pulsed lasers, one of which is tuneable in wavelength. The two laser beams are temporally and spatially overlapped before being focused on the sample. If the frequency difference between the two laser beams matches a Raman active vibrational mode, an anti-Stokes (blueshifted with respect to input beams) signal is produced. Raman vibrational modes are specific for compounds or groups of compounds providing chemically specific images. As the CARS signal is produced only within the focal volume of the lasers, the process is inherently confocal, allowing resolution down to the diffraction limit in three dimensions.
CARS is a third order non-linear optical technique that probes the same molecular vibrational frequencies as spontaneous Raman techniques. This means that CARS spectra are comparable to but not the same as Raman spectra. Coherent Raman techniques such as CARS have about 100 times faster imaging speed when compared to spontaneous Raman mapping techniques [19] . Spontaneous Raman techniques collect information over a wide spectral range, while narrowband coherent Raman techniques collect information from only a single Raman shift. Broadband coherent Raman techniques are able to probe a wider spectral region (600-3200 cm
À1
) but with a reduced spectral resolution (about 10 cm
) and a slower imaging speed (50 ms/pixel) when compared to narrowband coherent Raman techniques [20] . As CARS produces anti-Stokes shifted signal (blueshifted with respect to excitation pulses), it is free from single photon fluorescence, which hampers spontaneous Raman measurements. Unlike spontaneous Raman where the anti-Stokes scattering is much weaker than the Stokes scattering, the CARS process actively drives molecules into a specific vibrational mode and therefore generates significantly more signal with reduced temperature sensitivity.
CARS microscopy has been used to image a few pharmaceutical systems during drug release. Kang et al. [21] [22] [23] published work where they imaged in situ release of paclitaxel from polymeric films in a static medium (phosphate buffer) using CARS microscopy. In the first work focusing on orally administered drugs and dosage forms, Windbergs et al. [24] and Jurna et al. [25] used CARS microscopy to image the distribution of TP in lipid dosage forms and monitored the release of TP during dissolution in a flow through cell setup. They were able to image both drug release and conversion from TPa to TPm in real time.
We have developed a new analytical technique to record the dissolved drug concentration and simultaneously monitor solidstate changes on the surface of the oral solid dosage form undergoing dissolution. Furthermore, we have applied hyperspectral CARS microscopy for improved solid-state form characterization. We illustrate the use of these techniques using the model drug theophylline (TP) in different dissolution media.
Materials and methods

Materials
USP grade theophylline (TP, 1,3-dimethyl-7H-purine-2,6-dione) anhydrate and monohydrate were gifted from BASF (Ludwigshafen, Germany). Methyl cellulose (MC) (Methocel A4C premium) was gifted from Colorcon GmbH (Idstein, Germany).
Compact preparation
Weighed amounts of TPa and TPm (0.49 g) were directly compressed using a force feed tablet press (IMA Kilian Pressima, Italy). The upper punch had a pre-compression height of 9.22 mm and a final compression height of 3.02 mm using a compaction force of about 13 kN, resulting in compacts which had a diameter of 12.02 mm and a thickness of about 3 mm. The compression did not result in changes in the solid-state form, which we confirmed using hyperspectral CARS microscopy.
Methods
CARS microscopy
The CARS microscopy system is illustrated in Fig. 1 and is described in more detail elsewhere [26] . A Nd:YVO 4 picosecond pulsed laser (Coherent Inc., USA) operating at a fundamental wavelength of 1064 nm was frequency doubled to pump an optical parametric oscillator (OPO) (APE Berlin GmbH, Germany), which produced two dependently tunable laser beams. The fundamental laser beam was combined with the signal beam from the OPO and directed into an inverted laser-scanning microscope (Olympus IX71/FV300, Japan) where they were focused onto the sample using a 20Â/0.5 NA objective. The backscattered CARS signal was collected by the focusing objective, spectrally filtered to remove the excitation wavelengths, and detected with a photomultiplier tube (Hamamatsu R3896, Japan). The CARS microscope system had an axial spatial resolution of about 10 lm and a lateral spatial resolution of about 1 lm.
Hyperspectral CARS imaging
Hyperspectral CARS imaging provides a method to rapidly and visually confirm the solid-state form on the surface of an oral dosage form, both pre-and post-dissolution. Hyperspectral CARS images were obtained by rapidly imaging the sample while slowly sweeping the wavelength of the OPO in discrete steps, so that each frame in the image stack corresponds to a different vibrational frequency [26] . A color look up table was then applied to the image stack, with a separate color applied to each frame in the image. Finally, the frames were projected together, resulting in a single two-dimensional image wherein each material appears with a unique color. This process is illustrated as a diagram in Fig. 2 . In this study, 512 Â 512 pixel hyperspectral images were collected over a range of 100 cm À1 with each hyperspectral image taking approximately 2 min to record. CARS spectra shown in this article are pixel intensity profiles across the vibrational frequencies and were extracted from the hyperspectral image data. Further information about the collection of CARS spectra can be found in Garbacik et al. [26] .
In situ CARS dissolution imaging
In situ CARS images (512 Â 512 pixels) covering 350 Â 350 lm were recorded every 1.12 s (roughly 4.3 ls/pixel dwell time) for the duration of the dissolution experiments (15 min). All in situ CARS images recorded during dissolution testing were recorded at 2952 cm À1 and were false colored green. This peak has been assigned to antisymmetric C-H stretching in the methyl groups [27] and provided a strong CARS signal for both TPa and TPm.
Dissolution
A deuterium light source (DT-MINI-2, Ocean Optics, The Netherlands) was connected by an optical fiber to a Z-shaped flow cell (FIA-Z-SMA, Ocean Optics, The Netherlands) with a 10 mm path length An optical fiber connected the Z-shaped flow cell to a CCD spectrometer (USB2000+, Ocean Optics, The Netherlands). Open loop channel flow through intrinsic dissolution was conducted using a peristaltic pump (Reglo, ISMATEC, Germany), which pumped dissolution medium (distilled water or methyl cellulose 0.45% w/v) through the custom built CARS microscopy dissolution flow cell and through the Z-shaped UV flow cell at a rate of 5 mL/ min. UV spectra were collected at 290 nm every 30 s. Dissolution was conducted multiple times on each sample to check for consistency.
Results and discussion
Hyperspectral CARS analysis of TPa and TPm
CARS spectra of the C-H stretch region were collected prior to dissolution experiments on pure TPa and TPm to identify an appropriate vibrational frequency at which to record CARS images during dissolution experiments and for comparison to the before and after dissolution hyperspectral scans of the compacts. The C-H stretch region was chosen as TP has an intense signal in that region for both solid-state forms (Fig. 3) . Both TPa and TPm featured a peak at around 2950 cm À1 , which has been assigned to antisymmetric C-H stretching in the two methyl groups (m as C (1,3)-H 3 ) [27] . There was a peak shift between the two forms in the C-H stretching region of the spectra at a higher Raman shift, with the TPa peak at around 3120 cm À1 and the TPm peak at around 3105 cm À1 . This peak has been assigned to the imidazole ring C-H stretching (mC (8) -H), and the redshift is due to C (8) -HÁ Á ÁO intermolecular hydrogen bonding in the TPm form [27, 28] . The peak shift allowed us to visualize the change in anhydrate to monohydrate using hyperspectral imaging. However, the shifting peak was not suitable for single-frequency CARS dissolution imaging because it was not possible to simultaneously image the TPm crystal growth on the surface of a TPa compact. Since both TPa and TPm produce a strong signal at 2952 cm À1 , single-frequency CARS images were recorded at this Raman shift during dissolution experiments to allow visualization of both TPa and TPm simultaneously. Additionally, at 2952 cm
À1
, there is very little interference due to the presence of water.
Hyperspectral images were recorded before and after dissolution experiments to allow a rapid visual confirmation of the solidstate conversion on the surface of the compact which would be evident as a change in color. Fig. 4A shows the pre-dissolution hyperspectral image for a TPa compact, while Fig. 4B shows the post-dissolution hyperspectral image for the same TPa compact recorded after the duration of one dissolution experiment (15 min) using water as dissolution medium. The color change between Fig. 4A and B is due to the mC (8) -H peak shift in CARS spectra, indicating that the TP on the surface has converted to TPm form.
The CARS spectra were collected before and after each dissolution experiment for comparison with the reference spectra (Fig. 3) and to confirm the solid-state conversion observed in the dissolution images. Fig. 5 shows the pre-dissolution (black line) and postdissolution (red dashed line) CARS spectra for a TPa compact after dissolution using water as the dissolution medium. The CARS spectra confirm the observed shift in the peak from around 3120 cm
(before) to 3105 cm À1 (after), indicating the conversion from TPa to TPm on the surface of the compact.
In situ analysis of TP during dissolution testing
Theophylline in water dissolution
Single-frequency CARS images (512 Â 512 pixels) were recorded at 2952 cm À1 approximately every second for the duration of the dissolution experiments (15 min). Fig. 6 shows snapshots of the dissolution imaging from dissolution conducted using water as dissolution medium. From Fig. 6 , it is apparent that the TPm nucleation and crystal growth begin almost immediately after the beginning of the dissolution experiment with TPm crystals (needle shape) growing outwards from two nuclei on the surface of the compact. After 2 min, about half of the field of view is covered in TPm crystals, and it appears that most of the field of view is completely covered in TPm after about 4 min.
Ultraviolet spectra were collected every 30 s during the dissolution experiment to determine the dissolution rate profiles for TPa and TPm in our channel flow cell system. Fig. 7 shows the dissolution profiles for TPa (solid lines) and TPm compacts (dashed lines). From Fig. 7 , it can be seen that TPa initially increases to peak values of between 150 and 190 lg/mL, while the TPm reaches concentrations of between 70 and 80 lg/mL. Subsequently, there is a sharp drop in the first few minutes of the TPa dissolution that is not seen for the TPm dissolution. This change in dissolution behavior is due to a solvent-mediated transformation wherein the dissolving TPa (solubility 12 mg/mL at 25°C [29] ) reaches supersaturation which causes precipitation and growth of the more stable but less soluble TPm (solubility 6 mg/mL at 25°C [29] ) crystals that grow on the surface of the TPa compacts during dissolution. The surface growth of TPm on TPa samples undergoing dissolution has also been observed in other studies, using offline XRPD analysis [17] and inline spontaneous Raman spectroscopy [10, 30] .
The UV data shown in Fig. 7 correlate well with the CARS images (Fig. 6) that were recorded during the dissolution experiments. The dissolution rate peaked after about 2 min which related to about half of the microscope field of view covered in TPm needle-shaped crystals. After about 5 min, the dissolution rate reached a plateau at the same time the crystal growth appeared to completely cover the field of view. Fig. 7 shows that the TPm dissolution rate quickly reached a steady state after around 1 min and remained there for the duration of the experiment. The steady-state dissolution rates were calculated to be 360 ± 37 lg/min/cm 2 and 320 ± 12 lg/min/cm 2 for the compacts prepared from TPa and TPm, respectively. The slightly higher dissolution rate (not statistically significant) for the compacts originally composed of TPa after surface conversion to TPm can be attributed to the TPm needle growth resulting in a larger surface area.
Theophylline in methyl cellulose solution dissolution
In situ CARS dissolution imaging identified delayed TPm crystal growth on the surface of TPa compacts undergoing dissolution using a MC solution (0.45% w/v) as the dissolution medium. Fig. 8 shows in situ single-frequency CARS snapshots taken from a dissolution video. The TPm crystal growth was delayed as it was first observed after approximately 300 s (5 min), and the surface coverage with TPm was incomplete after the duration of the experiment (15 min). Additionally, the TPm crystals were of a different morphology than previously seen when using water as the dissolution medium. Instead of the thin needle-like structure seen growing in water, there was a broad almost sheet-like growth along the surface of the compact.
The delayed onset of crystal growth and different morphologies suggests that the polymer affects both nucleation and crystal growth. It has been suggested that the polymer adsorbs to the surface of the TPa particles, and this leads to inhibition of heterogeneous nucleation, while the changed crystal morphology is likely to be due to preferential adsorption to specific crystal faces of TPm, which, in turn, affects their relative growth rates [12] .
The delayed TPm crystal growth seen in the CARS dissolution imaging (Fig. 8 ) was expected to affect the TPa dissolution rate and Fig. 9 shows that this was the case. Fig. 9 shows the dissolution profiles for TPa and TPm compacts undergoing dissolution using MC solution as the dissolution medium. From Fig. 9 it can be seen that the characteristic decrease in dissolution rate associated with TPm growth on the surface of TPa compacts (Fig. 7) is no longer seen. Instead the TPa compacts reach a concentration of about 150 lg/mL and remain there for the duration of the experiment.
The dissolution behavior of the TPm compacts appear minimally affected by the use of the MC dissolution medium as they reach a concentration of about 80 lg/mL and remain there for the duration of the experiment. This concentration is the same as was observed for water without the polymer, revealing that the solubility of the drug is not affected by the polymer in solution, and therefore the different dissolution profiles obtained with and without polymer solution are not solubility mediated. The steady-state intrinsic dissolution rates were calculated to be 700 ± 130 lg/min/cm 2 and 350 ± 40 lg/min/cm 2 for the compacts prepared from TPa and TPm respectively (assuming both compacts had a perfectly planar surface). Since the solubility of the TPa is twice that of TPm in water at 25°C [29] , a two-fold increase in the dissolution rate of the compact prepared from TPa would theoretically only be expected if there were no conversion to the monohydrate. However, an increase in surface area of the compacts prepared from TPa after TPm formation was observed in water which affected the dissolution behavior, and therefore a surface area increase can also be expected to affect the dissolution profiles in the polymer solution. Additionally, from Fig. 9 there are noticeable fluctuations in the steady-state concentrations (when compared to Fig. 7 ) of both TPa and TPm this is attributed to bubbles in the dissolution medium not removed by sonication. The inherent confocality, chemical specificity, and speed provided by CARS microscopy increases the spatial and chemical resolution of the system providing advantages over existing approaches including traditional optical microscopy and Raman microscopy based on spontaneous Raman scattering. The biggest advantage when compared to traditional optical microscopy is the fact that the detected signal is generated when the excitation beams match the Raman vibrational mode for the chemical of interest this provides chemical selectivity. If the excitation laser frequencies are incorrect or the sample is the wrong chemical then no resonant signal is generated. The inherent confocal nature means that the morphological information is resolved to approximately 10 lm in the depth direction, a resolution that is not obtained with traditional optical microscopy.
Conclusions
We used CARS microscopy to image in situ solid-state conversions of samples during dissolution in real time. The combination of CARS microscopy with flow through UV absorbance spectroscopy allowed us to correlate the visualized polymorphic conversion with changes in dissolution rates. Additionally the inhibition of TPm crystal growth due to the presence of MC was correlated with changes in dissolution rate for TPa compacts. Hyperspectral CARS microscopy provided a rapid visual technique to confirm the polymorphic conversion that occurred during dissolution. The combination of the rapid analysis and chemical selectivity of CARS and hyperspectral CARS with UV absorption spectroscopy has the potential to allow improved characterization of solid dosage forms undergoing dissolution. CARS with UV absorption spectroscopy allows further in depth analysis on dosage forms exhibiting unexpected dissolution profiles, including failed dissolution tests. Improved characterization of solid dosage forms undergoing disso- lution will help in the development of formulations where dissolution profiles are especially important. Formulations such as those containing a poorly soluble APIs and controlled release formulations, where bioavailability is dissolution-or release-rate limited will benefit from improved characterization.
